Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.


Figure S1. CCL25 induces y5 T-cell transmigration mediated by a4p7 integrin.

Figure S2. Effect of in vivo pretreatment with anti-CCL25 mAb on OVA-induced IFN-y+ or IL-4+ y5 T lymphocyte accumulation.

Figure S3. CCL20 neutralization decreases IL-17+ y5 T-cell chemotaxis toward OPW.

Figure S4. Expression of the chemokine receptors CCR2, CCR6, and CCR9 by a4p7+y5T lymphocytes.

Figure S5. Gating strategy used for flow cytometry analysis of y5 cells expressing CCR6, CCR9, and a4p7 integrin.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.